-
The consistency evaluation of generic drugs is "high prosperity continuous", and 2 varieties of one pharmaceutical company have been evaluated
Time of Update: 2022-10-13
Two varieties of Lisheng Pharmaceutical passed the consistency evaluation Recently, the application for consistency evaluation supplement of two varieties of Lisheng Pharmaceutical Folic Acid Tablets and Hydrochlorothiazide Tablets was approved by the State Drug Administration, which further demonstrated the company's research and development strength and product quality.
-
Institutions gathered to investigate pharmaceutical CXO enterprises, and the number of 4 companies was more than 100
Time of Update: 2022-10-13
Some analysts said that pharmaceutical research and development investment will continue to grow, and the penetration rate of research and development outsourcing services will continue to increase, which will help maintain the high prosperity of the CXO industry.
-
Third quarter forecast: The performance of related companies in the pharmaceutical and biological industry is remarkable
Time of Update: 2022-10-13
According to the data, BGI Intelligent Manufacturing is an enterprise focusing on the field of life sciences and biotechnology, with the research and development, production and sales of related products such as instruments and equipment, reagents and consumables as its main business.
-
Enterprises in Lhasa have produced a total of 4.122 million masks and 1,350 tons of disinfectant
Time of Update: 2022-10-13
employment In the next step, in accordance with the deployment requirements of the district and municipal party committees and governments on the overall prevention and control of the epidemic and economic and social development, the Lhasa Municipal Bureau of Economy and Information Technology will resolutely implement the important instructions and requirements of "the epidemic should be prevented, the economy should be stabilized, and the development should be safe", and orderly and steadily promoted the resumption of work and production.
-
In the first half of 2022, the sales of 3 anti-tumor drugs in the hospital exceeded 2 billion yuan
Time of Update: 2022-10-13
Among them, in the first half of 2022, anti-tumor drugs with higher sales in the hospital include bevacizumab injection, trastuzumab for injection, ositinib mesylate tablets, paclitaxel for injection (albumin-conjugated), goserelin acetate extended-release implant, etc.
-
Shanghai Municipal Action Plan for Healthy Aging (2022-2025)
Time of Update: 2022-10-13
District Health Commission, Development and Reform Commission, Science and Technology Commission, Economic Committee (Commerce Commission), Education Bureau, Civil Affairs Bureau, Finance Bureau, Hum
-
The ophthalmic treatment track has begun, and domestic and foreign pharmaceutical companies are competing for layout
Time of Update: 2022-10-13
With the increasing aging of the population and the increase in the use of electronic products, age-related eye diseases, metabolic-related eye diseases, and fundus lesions caused by high myopia are
-
Jiangsu Pharmaceutical Medical Consumables Sunshine Procurement Service Network was officially launched
Time of Update: 2022-10-13
(End) On October 9, Jiangsu Pharmaceutical Medical Consumables Sunshine Procurement Service Network was officially put into operation, which is another important measure for the Jiangsu Provincial Medical Security Bureau to continuously optimize the business environment in accordance with the requirements of "reducing links, reducing costs and opening channels" to support the innovation and development of the pharmaceutical industry.
-
Announcement of the State Food and Drug Administration on the issuance of electronic registration certificates for drugs
Time of Update: 2022-10-13
In order to implement the important decision-making and deployment of the Party Central Committee and the State Council on deepening the reform of "decentralization and management of services", optimize the business environment, further stimulate the development vitality of market players, and provide enterprises with more efficient and convenient government services, after research, it was decided to issue electronic registration certificates for drugs from November 1, 2022.
-
The pharmaceutical circulation link has ushered in a reshuffle period, and a large number of enterprises are seeking the road to listing
Time of Update: 2022-10-13
Prior to Hengchang Pharmaceutical, the same category of enterprise Huaren Health also submitted an IPO prospectus for the ChiNext Board in May 2021, with the intention of raising 600 million yuan.
-
Opinions on reforming and improving the management of the review and approval of radiopharmaceuticals
Time of Update: 2022-10-13
In order to encourage the declaration of research and development of radioactive drugs, the State Drug Administration has organized and drafted the Opinions on Reforming and Improving the Administrat
-
Expand the scope of "inter-provincial communication" of government services to further improve service efficiency
Time of Update: 2022-10-13
The people's governments of all provinces, autonomous regions and municipalities directly under the Central Government, and the ministries and commissions and agencies directly under the State Counci
-
New Chinese medicine drugs have gradually entered the harvest period, and 45 new Chinese medicine drugs have been accepted
Time of Update: 2022-10-13
Recently, the Drug Evaluation Center of the State Drug Administration issued a notice on the public solicitation of opinions on the "Technical Guidelines for the Preparation and Research of Drugs for Clinical Trial of Chinese Medicines for New Drugs (Draft for Comment)".
-
Ointment broke 6 billion for the first time, and the TOP10 sold well! Only 3 varieties have been reviewed
Time of Update: 2022-10-13
As a dosage form for transdermal administration, ointment is widely used in dermatology and surgery in hospitals. Since the beginning of this year, only Hubei Heng'an Fulin Pharmaceutical's tacrolimu
-
The development direction of the pharmaceutical equipment industry is gradually clear, and the future transformation and upgrading will continue to accelerate
Time of Update: 2022-10-13
In addition to accelerating innovation, promoting intelligent manufacturing has also become one of the development trends of the pharmaceutical equipment industry.
In addition to accelerating innovation, promoting intelligent manufacturing has also become one of the development trends of the pharmaceutical equipment industry.
-
Under the acceleration of chemical drug innovation, the industry will rapidly differentiate
Time of Update: 2022-10-13
The chemical preparation industry refers to the manufacture of chemical preparations directly used for the prevention and treatment and diagnosis of human diseases, and it has always occupied an impo
-
Sanshui, Foshan, Guangdong Province, has created a new growth pole for biomedicine in the Greater Bay Area
Time of Update: 2022-10-13
Guangdong Medical Valley Yundonghai Life Science Park, located in Yundonghai Street, Sanshui District, Foshan City, is under construction Courtesy of the Publicity Department of the Sanshui District P
-
Medical and health workers strive to protect people's health in an all-round and full-cycle manner
Time of Update: 2022-10-13
" Hu Xiaozhong, president of the health center, said that over the past few years, we have taken the general secretary's earnest instructions to heart, worked hard to build a modern health center, and strived to set an example so that the people can enjoy better basic medical services.
-
The first continuous manufacturing guide in China is coming, and the pharmaceutical industry will usher in major changes!
Time of Update: 2022-10-13
In order to encourage innovation and pharmaceutical modernization, to help the implementation of the ICH Q13 guidelines in China, but also to guide enterprises in research and development, unified re
-
Why has Hainan's gradual abolition of general outpatient clinics in tertiary public hospitals caused widespread concern?
Time of Update: 2022-10-13
This news stems from the "Implementation Plan for Promoting the High-quality Development of Public Hospitals in Hainan Province" issued by the General Office of the Hainan Provincial Government not long ago, which proposes to strictly control the number and scale of tertiary public hospitals in the next three to five years, and gradually cancel the general outpatient clinics in these hospitals.
